At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which is viewed as a key part of the drugmaker's growth strategy in HIV. The ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...

Research into cannabidiol (CBD) is ongoing, but early results suggest that it’s promising for helping with anxiety, pain, and sleep issues. If pain and anxiety are affecting your sleep, CBD may ...

Caroline Banton has 6+ years of experience as a writer of business and finance articles. She also writes biographies for Story Terrace. David Kindness is a Certified Public Accountant (CPA) and an ...

Objectives Comprehensive understanding of the technical aspects of medical aid-in-dying (MAiD) including candidate selection, clinician prescribing decisions, and complications in the USA has been ...

The final, formatted version of the article will be published soon. Purpose: To investigate the correlation between the medication regimen complexity index (MRCI) and adverse drug reactions (ADRs) ...